RT Journal Article
SR Electronic
T1 Two-stage neural-network based prognosis models using pathological image and transcriptomic data: An application in hepatocellular carcinoma patient survival prediction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.01.25.20016832
DO 10.1101/2020.01.25.20016832
A1 Zhucheng Zhan
A1 Noshad Hossenei
A1 Olivier Poirion
A1 Maria Westerhoff
A1 Eun-Young Choi
A1 Travers Ching
A1 Lana X. Garmire
YR 2020
UL http://medrxiv.org/content/early/2020/01/28/2020.01.25.20016832.abstract
AB Pathological images are easily accessible data type with potential as prognostic biomarkers. Here we extend Cox-nnet, a neural network based prognosis method previously used for transcriptomics data, to predict patient survival using hepatocellular carcinoma (HCC) pathological images. Cox-nnet based imaging predictions are more robust and accurate than Cox proportional hazards model. Moreover, using a novel two-stage Cox-nnet complex model, we are able to combine histopathology image and transcriptomics RNA-Seq data to make impressively accurate prognosis predictions, with C-index close to 0.90 and log-ranked p-value of 4e-21 in the testing dataset. This work provides a new, biologically relevant and relatively interpretable solution to the challenge of integrating multi-modal and multiple types of data, particularly for survival prediction.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is a secondary data analysis on public pathology and genomics dataset in TCGA.Funding StatementThe work is support by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (www.bd2k.nih.gov), R01 LM012373 and LM012907 awarded by NLM, R01 HD084633 awarded by NICHD to L.X. Garmire.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study is publicly available.gs://gdc-tcga-phs000178-open/